期刊文献+

HLA-B27对中国人群强直性脊柱炎诊断价值的Meta分析 被引量:3

Diagnostic Value of HLA-B27 Tests for Ankylosing Spondylitis in Chinese Population:A Meta-analysis
原文传递
导出
摘要 目的探讨HLA-B27对中国人群强直性脊柱炎(AS)的诊断价值。方法计算机检索Pub Med、EMbase、The Cochrane Library(2015年8期)、CNKI以及WanFang Data数据库,搜集国内外发表的关于HLA-B27诊断中国人群AS的诊断性试验,检索时限均从建库至2015年8月。由2位研究者独立筛选文献、提取资料和评价纳入研究的方法学质量后,采用Stata 12.0软件进行统计分析。结果共纳入16个研究,共计3 137例AS患者,5 617例疑似AS患者。Meta分析结果显示,HLA-B27诊断AS的Sen_(合并)=0.91[95%CI(0.89,0.93)]、Spe_(合并)=0.94[95%CI(0.91,0.96)]、+LR_(合并)=14.90[95%CI(9.60,23.10)]、–LR_(合并)=0.09[95%CI(0.08,0.12)]、DOR_(合并)=157[95%CI(90,275)]、AUC=0.95[95%CI(0.93,0.97)]。结论 HLA-B27检测对中国人群AS诊断价值较高。基于现有研究的缺陷,本研究结论尚需开展更多长期随访的前瞻性研究予以证实。 Objective To explore the diagnostic value of HLA-B27 for ankylosing spondylitis (AS) in Chinese population. Methods We searched PubMed, EMbase, The Cochrane Library (Issue 8, 2015), CNKI, and WanFang data from inception to August 2015, to collect diagnostic studies about HLA-B27 for AS in Chinese population. Two reviewers independently screened literature, extracted data, and assessed the methodological quality of included studies. Then meta- analysis was performed by using Statal2.0 software. Results A total of 16 studies involving 3 137 AS and 5 617 suspect patients were finally included. The results ofmeta-analysis showed that the pooled Sen, Spe, +LR, -LR and DOR were 0.91 (95%CI 0.89 to 0.93), 0.94 (95%CI 0.91 to 0.96), 14.90 (95%CI 9.60 to 23.10), 0.09 (95%CI 0.08 to 0.12) and 157.00 (95%CI 90.00 to 275.00), respectively. The AUC of SROC was 0.98 (95%CI 0.93 to 0.97). Conclusions HLA-B27 detection is of great diagnostic value for AS in Chinese population. However, due to the limited quality and quantity of the included studies, more long-term follow-up prospective studies are needed to verify the above conclusion.
出处 《中国循证医学杂志》 CSCD 2016年第7期802-808,共7页 Chinese Journal of Evidence-based Medicine
关键词 HLA—B27 强直性脊柱炎 诊断性试验 中国人 META分析 HLA-B27 Ankylosing spondylitis Diagnostic test Chinese population Meta-analysis
  • 相关文献

参考文献31

  • 1黎勤云,李志强.强直性脊柱炎相关HLA-B27的研究进展[J].中国输血杂志,2012,25(11):1138-1140. 被引量:5
  • 2Dougados M, Paternotte S, Braun I, et al. ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis. Ann Rheum Dis, 2011, 70(2): 249-251.
  • 3Linden S, Valkenburg H, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum, 1984, 27(4): 361-388.
  • 4Rachid B, Zorkany B, Youseif E, et al. Early diagnosis and treatment of ankylosing spondylitis in Africa and the Middle East. Clin Rheumatol, 2012, 31(11): 1633-1639.
  • 5Popa O, Bojinca M, Bojinca V, et al. Distribution of HLA-B27 in Romanian spondyloarthritides patients, lnt ] Immunopharmacol, 2010, 37(6): 513-516.
  • 6Acar M, Cora T, Tunc R, et al. HLA-B27 subtypes in Turkish patients with ankylosing spondylitis and healthy controls. Rheumatol lnt, 2012, 32(10): 3103-3105.
  • 7蒋娟,熊小敏,张卫云,李薇.人白细胞抗原HLA-B27在强直性脊柱炎中的临床意义[J].生物技术通讯,2014,25(3):410-411. 被引量:7
  • 8于莉.PCR-SSP法、FCM法及MLCT法检测强直性脊柱炎患者HLA-B_(27)对比分析[J].风湿病与关节炎,2014,3(10):13-15. 被引量:4
  • 9艾金伟,李德胜,刘羽,林洪明,王谦,裴斌.国内HLA-B27诊断强直性脊柱炎价值的Meta分析[J].中国循证医学杂志,2015,15(9):1059-1067. 被引量:13
  • 10Moher D, Liberati A, Tetzlaff J, et al. Reprint-preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Phys Ther, 2009, 89(9): 873-880.

二级参考文献261

共引文献262

同被引文献22

引证文献3

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部